CVS Health (CVS) Q2 medical benefit ratio (MBR)?: how this market works

What you need to know

This market asks how much of every dollar CVS Health collected in health insurance premiums it paid out in medical claims during Q2 2025 (the second quarter of CVS's fiscal year). The medical benefit ratio, or MBR, is simply that share: if CVS spent 88 cents on medical care for every dollar it took in, the MBR is 88%. A lower MBR means the insurance side of the business kept more money; a higher MBR means more went to paying claims. The market is asking which range that number falls into. When CVS publishes its Q2 earnings, the market settles based on the MBR figure in those official materials, press releases, or regulatory filings. If the number is below 87.5%, it resolves to the lowest bracket. If it falls between 87.5% and 89%, it resolves to the middle bracket. If it hits 92% or above, it resolves to the highest bracket. One important edge case: if CVS does not publish earnings by August 31, 2026, or if the MBR is simply not reported, the market automatically resolves to the lowest bracket, which represents below 87.5%. None of the provided recent headlines relate to CVS Health or its Q2 financial results. To follow this market, the news worth watching would be CVS's official Q2 earnings release, any guidance updates the company gives about medical costs, and broader signals about how much Americans are using healthcare services, since higher utilization tends to push the MBR up. The MBR is genuinely hard to forecast because it depends on how many people used healthcare services during the quarter, and how expensive those services were, neither of which CVS fully controls. The market currently puts a 60% chance on the MBR coming in below 87.5% and a 36% chance on the 87.5% to 89% range, so it leans toward the lower bracket but not overwhelmingly. The main unknowns are whether medical utilization surprised on the high side and how well CVS managed costs, details only the earnings report will confirm.

The odds right now

• <87.5%60%
• 87.5%-89%36%
• 89%-90.5%5%
• 90.5%-92%2%
• 92%+2%

Price history

How this resolves

Resolves July 30, 2026

This market will resolve according to CVS Health's medical benefit ratio (MBR) for the upcoming second fiscal quarter, as reported in its official company earnings materials. The specified metric will be considered as reported in the company's official earnings materials. Read the full resolution rules on the live market page.

Related

Same markets. A fraction of the fee.

These apps all route to the same exchange order book. The difference is what each one adds on top of the exchange's own fee.

Published rates, checked July 2026. MetaMask charges a flat 4 percent per prediction trade. Jupiter adds a fee equal to the exchange's own taker fee at fill time, roughly 2 to 4 percent at typical odds. Where a market carries an exchange settlement fee, it applies everywhere, whichever app you use. Paridesk adds nothing on maker orders.

Trade this market on Paridesk: non-custodial, 0.5% fee.